BRD4 and brain injury: Furthermore, targeted degradation of the BRD4 protein using dBET1 has been shown to improve outcomes in acute ischemic brain injury, with benefits including decreased neuroinflammation, reduced oxidative stress, and the maintenance of blood–brain barrier integrity [33].